415 results on '"Chahoud, Jad"'
Search Results
2. A clinical overview of people living with HIV and genitourinary cancer care
3. Correction to: Current Status and Challenges in Rare Genitourinary Cancer Research and Future Directions
4. Immune-based Therapies for Penile Cancer
5. Overview of Systemic Therapies in Penile Cancer
6. Pathogenic Roles for RNASET2 in Clear Cell Renal Cell Carcinoma
7. 15 years of patient-reported outcomes in clinical trials leading to GU cancer drug approvals: a systematic review on the quality of data reporting and analysis
8. Diagnosing and Staging Patients with Penile Cancer
9. Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial
10. Cost Effectiveness of Treatment Sequences in Advanced Renal Cell Carcinoma
11. The Evolving Landscape of Viral, Immune, and Molecular Biomarkers in Penile Cancer
12. Immune-based therapies in penile cancer
13. Diagnosing and Staging Patients with Penile Cancer
14. Clinical Cases Debate: Neoadjuvant Versus Adjuvant Immunotherapy in Localized Renal Cell Carcinoma (RCC)
15. MP61-15 TRANSCRIPTOMIC, PROTEOMIC, AND GENOMIC MUTATIONAL FRACTION DIFFERENCES BASED ON HPV STATUS OBSERVED IN PATIENT DERIVED XENOGRAFT MODELS OF PENILE SQUAMOUS CELL CARCINOMA
16. TP53 Mutations Emerge as a Critical Biomarker in Penile Cancer, Superseding Human Papillomavirus Status
17. Penile cancer: Updates in systemic therapy
18. Proteogenomic, Epigenetic, and Clinical Implications of Recurrent Aberrant Splice Variants in Clear Cell Renal Cell Carcinoma
19. Examining the relationship between household wealth and colorectal cancer screening behaviors among U.S. men aged 45–75
20. Coordinated Pembrolizumab and High Dose IL-2 (5-in-a-Row Schedule) for Therapy of Metastatic Clear Cell Renal Cancer
21. Correlating Immune Cell Infiltration Patterns with Recurrent Somatic Mutations in Advanced Clear Cell Renal Cell Carcinoma
22. Evaluation of Patient-Reported Outcomes (PROs) Protocol Content and Reporting for Clinical Trials that Lead to the approval of frontline Immune Checkpoint Blockade Combination for Patients with Advanced Renal Cell Carcinoma - The Patients’ Voice or a Missed Opportunity
23. HPV and Penile Cancer: Epidemiology, Risk Factors, and Clinical Insights.
24. Overview of Insightful Systemic Approaches
25. Updated Results of Rituximab Pre- and Post-BEAM with or without 90Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell Lymphoma.
26. Insights into the management of penile squamous cell carcinoma: from conventional approaches to emerging novel therapies
27. Transcriptomic, Proteomic, and Genomic Mutational Fraction Differences Based on HPV Status Observed in Patient-Derived Xenograft Models of Penile Squamous Cell Carcinoma
28. Neoadjuvant platinum-based chemotherapy and lymphadenectomy for penile cancer: an international, multi-institutional, real-world study
29. Re: Bradley McGregor, Daniel M. Geynisman, Mauricio Burotto, et al. A Matching-adjusted Indirect Comparison of Nivolumab Plus Cabozantinib Versus Pembrolizumab Plus Axitinib in Patients with Advanced Renal Cell Carcinoma. Eur Urol Oncol. 2023;6:339–348
30. Pembrolizumab for advanced penile cancer: a case series from a phase II basket trial
31. Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations
32. Feasibility of a Smartphone Application for Education and Symptom Management of Patients With Renal Cell Carcinoma on Combined Tyrosine Kinase and Immune Checkpoint Inhibitors.
33. Inherited Germline Variants in Urinary Tract Cancer: A Multicenter Whole-Exome Sequencing Analysis and Correlation With Clinical Features and Tumor Genomics.
34. Current State of Cell Therapies for Genitourinary Malignancies
35. Increased spatial coupling of integrin and collagen IV in the immunoresistant clear cell renal cell carcinoma tumor microenvironment
36. 380 Exploring the microenvironment of clear cell renal cell carcinoma to improve therapy with tumor infiltrating lymphocytes
37. INNV-37. BELZUTIFAN IMPACT ON VHL-ASSOCIATED CNS HEMANGIOBLASTOMAS
38. Understanding genomics and the immune environment of penile cancer to improve therapy
39. Innovative systemic therapies for penile cancer
40. Phase I/II study of ipilimumab plus nivolumab (IPI-NIVO) combined with sacituzumab govitecan in patients with metastatic cisplatin-ineligible urothelial carcinoma.
41. A phase 2 study of the combination dostarlimab with niraparib in patients with penile carcinoma that has progressed following chemotherapy.
42. A multicohort phase 2 trial of ADT, docetaxel plus nivolumab in patients with de novo metastatic hormone-sensitive prostate cancer enriched for inflamed tumors and DNA damage repair defects.
43. Alterations in tumor immune microenvironment and progressive immune exhaustion with advancing penile squamous cell carcinoma using multiplex immunofluorescence and image analysis.
44. Cabozantinib plus pembrolizumab as first-line therapy for cisplatin-ineligible advanced urothelial carcinoma (PemCab).
45. The feasibility of an educational and monitoring smartphone application for patients with advanced renal cell carcinoma undergoing combination immunotherapy.
46. Disparities in uptake of new FDA-approved therapies for metastatic clear cell renal cell carcinoma.
47. Zanzalintinib in combination with immune checkpoint inhibitors: Design of the renal cell carcinoma expansion stage cohorts in STELLAR-002
48. Abstract B023: Using hypoxia to improve tumor infiltrating lymphocytes therapy in different subtypes of renal cell carcinoma
49. Immunotherapy in the Treatment of Localized Genitourinary Cancers
50. The Prognostic Role of Human Papillomavirus and p16 Status in Penile Squamous Cell Carcinoma—A Systematic Review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.